These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 10675273)

  • 1. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
    Kitamura H; Ohta A; Sekimoto M; Sato M; Iwakabe K; Nakui M; Yahata T; Meng H; Koda T; Nishimura S; Kawano T; Taniguchi M; Nishimura T
    Cell Immunol; 2000 Jan; 199(1):37-42. PubMed ID: 10675273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
    Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T
    Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
    Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.
    Carnaud C; Lee D; Donnars O; Park SH; Beavis A; Koezuka Y; Bendelac A
    J Immunol; 1999 Nov; 163(9):4647-50. PubMed ID: 10528160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
    Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells.
    Maeda M; Yanagawa Y; Iwabuchi K; Minami K; Nakamaru Y; Takagi D; Fukuda S; Onoé K
    Immunobiology; 2007; 212(7):537-47. PubMed ID: 17678711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
    Singh N; Hong S; Scherer DC; Serizawa I; Burdin N; Kronenberg M; Koezuka Y; Van Kaer L
    J Immunol; 1999 Sep; 163(5):2373-7. PubMed ID: 10452969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H2-D(d)-mediated upregulation of interleukin-4 production by natural killer T-cell and dendritic cell interaction.
    Mizuuchi K; Yanagawa Y; Iwabuchi K; Namba K; Kitaichi N; Ohno S; Onoé K
    Immunology; 2008 May; 124(1):102-11. PubMed ID: 18194275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice deficient in Vbeta8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction.
    Habu Y; Shinomiya N; Kinoshita M; Matsumoto A; Kawabata T; Seki S
    Clin Exp Med; 2007 Mar; 7(1):30-8. PubMed ID: 17380303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors.
    Biburger M; Tiegs G
    J Leukoc Biol; 2008 Jul; 84(1):264-79. PubMed ID: 18407967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high fat diet on NKT cell function and NKT cell-mediated regulation of Th1 responses.
    Miyazaki Y; Iwabuchi K; Iwata D; Miyazaki A; Kon Y; Niino M; Kikuchi S; Yanagawa Y; Kaer LV; Sasaki H; Onoé K
    Scand J Immunol; 2008 Mar; 67(3):230-7. PubMed ID: 18226013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Repeated administration of alpha-galactosyl ceramide attenuates of natural killer T cells].
    Minagawa M; Iiai T; Sato Y; Yamamoto S; Hatakeyama K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1553-5. PubMed ID: 16315866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
    Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
    J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K; Exley MA; Jiang X; Ohkochi N; Taniguchi M; Seino K
    Cancer Res; 2006 Dec; 66(23):11441-6. PubMed ID: 17145891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S; Shimizu K; Hemmi H; Steinman RM
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.
    Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA
    J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.